Systematix Corporate Services Limited has announced the appointment of Ms. Rupam Lal Das as Joint Managing Director and Senior Management Personnel of the Company, effective May 08, 2026. The decision was taken through a circular resolution passed by the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is noted that Ms. Das's role as Joint Managing Director does not form part of the Board of Directors of the Company.

Appointment Details

The key details of the appointment, as disclosed in compliance with Regulation 30 of the SEBI Listing Regulations, are summarised below:

Professional Profile

Ms. Rupam Lal Das is an experienced Investment Banking professional with over 15 years of experience across Investment Banking, Capital Markets, M&A, Private Equity, and Healthcare & Pharmaceutical sector coverage. She was associated with JM Financial as Director – Healthcare & Pharmaceutical Coverage and has previously worked with reputed organisations including Anand Rathi Advisors, Edelweiss Financial Services, and Motilal Oswal Investment Advisors.

She has successfully led and executed multiple high-value IPOs, M&A, and fundraising transactions across the healthcare and pharmaceutical sectors, with strong industry relationships and extensive transaction experience.

Academic Background

Ms. Das holds strong academic credentials that complement her professional expertise:

• Post Graduate Program in Management (Finance & Operations) from Indian School of Business (ISB), Hyderabad
• Bachelor's degree in Electrical Engineering from BIT Sindri

Regulatory Compliance

The appointment disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The intimation was signed by Divyesh Badiyani, Company Secretary & Compliance Officer of Systematix Corporate Services Limited.

Systematix Corporate Services announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, approved at the Board of Directors meeting held on April 29, 2026. The diversified financial services firm reported steady revenue growth on a standalone basis, recommended a final dividend of 10%, and undertook several strategic corporate actions during the period.

FY26 Standalone Financial Performance

The company's standalone results reflected positive revenue momentum alongside continued investments in growth platforms. The following table summarises key standalone income statement metrics for the year and the latest quarter:

FY26 total income from operations stood at approximately ₹146.17 crores, reflecting 5% year-on-year growth over ₹139.39 crores in FY25. Profitability for the full year was supported by core merchant banking and service revenues, while Q4 FY26 recorded a standalone net loss of ₹351.69 lakhs, partly impacted by an exceptional item of ₹1.53 lakhs related to the one-time impact of new Labour Codes. Employee benefits expense for FY26 stood at ₹1,692.92 lakhs versus ₹1,488.82 lakhs in FY25, and depreciation and amortisation increased to ₹351.00 lakhs from ₹237.15 lakhs.

Standalone Balance Sheet Highlights

The standalone balance sheet as at March 31, 2026 reflects significant growth in investments and fixed assets, alongside a reduction in cash and bank balances. Key figures are presented below:

Investments surged to ₹13,045.00 lakhs from ₹8,149.53 lakhs, reflecting capital deployment into growth platforms. Total equity (share capital plus other equity) strengthened to ₹24,258.65 lakhs from ₹21,735.26 lakhs.

Standalone Cash Flow Summary

The standalone cash flow statement for the year ended March 31, 2026 showed robust operating cash generation, offset by significant investing outflows.

The closing balance of ₹12,046.69 lakhs comprises cash on hand of ₹0.17 lakhs, current account balances of ₹1,282.83 lakhs, FDR with bank (own fund) of ₹4,056.29 lakhs, FDR with bank (out of funds raised through preferential allotment) of ₹6,694.90 lakhs, and earmarked bank balances (unpaid dividend) of ₹12.49 lakhs.

FY26 Consolidated Financial Performance

On a consolidated basis, Systematix and its subsidiaries reported total income of ₹14,761.06 lakhs for FY26 compared to ₹16,886.79 lakhs in FY25. Net profit from continuing operations for FY26 stood at ₹1,383.71 lakhs against ₹4,576.13 lakhs in the prior year. The consolidated results include the performance of five audited subsidiaries and one unaudited subsidiary (Urban Affordable Housing LLP).

Consolidated total assets stood at ₹43,538.76 lakhs as at March 31, 2026 versus ₹42,833.07 lakhs a year earlier. Other equity on a consolidated basis was ₹30,019.93 lakhs compared to ₹28,611.61 lakhs. The consolidated net cash used in operating activities was ₹(805.09) lakhs for FY26, with net cash used in investing activities of ₹(1,690.02) lakhs and net cash used in financing activities of ₹(563.44) lakhs, resulting in a net decrease in cash and cash equivalents of ₹(3,058.55) lakhs.

Consolidated Segment Performance

The company operates across three reportable segments. Segment-wise revenue and results for FY26 are presented below:

Business Development Highlights

The Investment Banking division advised and executed transactions aggregating approximately ₹4,600 crores during FY26 across IPOs, QIPs, Rights Issues, Buybacks, Block Deals, Private Equity and M&A. The company maintains a robust active transaction pipeline of ₹11,600 crores across 27+ opportunities. Systematix completed a fund raise in Category I AIF with a target AUM of ₹125 crores and is targeting to raise up to ₹1,000 crores in Category II AIF for a Pre-IPO and Secondaries Fund. The formal launch of the Private Wealth Business marked a significant milestone, with senior leadership hires and offices established in Mumbai, Ahmedabad, Delhi and Kolkata.

Board Decisions and Corporate Actions

At the Board meeting held on April 29, 2026, the following key decisions were taken in addition to the approval of financial results:

• Final Dividend: Recommended a final dividend of ₹0.10 per equity share of ₹1 face value (10%) for FY26, subject to shareholder approval at the ensuing Annual General Meeting.
• Internal Auditor Appointment: Appointed Mr. Pradeep Gotecha, Chartered Accountant, as Internal Auditor of the Company for Financial Year 2026-27. Mr. Gotecha has 23 years of experience in the fields of Accounts, Legal and Compliance.
• Subsidiary Strike-Off: Approved filing an application for striking off the name of Divisha Alternative Investments LLP, a subsidiary LLP that has remained inoperative since incorporation and has not carried on any business. The company confirmed this LLP is not a material subsidiary and the action will have no material impact on operations or financial position.
• Insider Trading Code Amendment: Amended the Code of Conduct for Prevention of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, effective April 29, 2026.

Management Commentary

Mr. Nikhil Khandelwal, Managing Director, commented on the results: "FY26 was a year of strategic execution and platform building. We continued to strengthen our core businesses while investing in new growth areas such as Private Wealth and Asset Management. Our diversified model, strong transactions pipeline and expanding leadership team position us well for the next phase of growth."

The statutory auditors M/s. Shah & Taparia, Chartered Accountants, issued an unmodified audit opinion on both the standalone and consolidated audited financial results for the year ended March 31, 2026.